Ypsomed Holding AG, Roche Holding AG, Eli Lilly & Co., Novo Nordisk A/S

    Bonus Amount: 1,200.00 CHF  |  Currency: CHF  |  Maturity: 21/09/2026

    %
    CHF Nominal

    %
    CHF Nominal

    Product Overview

    Underlyings
    Key figures
    Bonus amount of denomination
    120.00%
    Denomination
    1,000.00 CHF
    Distance to Barrier
    20.10%

    Life Cycle

    Initial FixingFirst trading dayLast trading dateFinal fixingRedemption

    Product Information

    Key Information Document
    Termsheet
    Base Prospectus